Navigation Links
Arpida Announces Full Year 2007 Financial Results
Date:3/13/2008

REINACH, Switzerland, March 13 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) announced today its financial results for the year ending 31 December 2007.

2007 highlights

Major pipeline progress:

- Second pivotal Phase III trial with intravenous iclaprim in cSSSI achieves its pre-specified primary endpoint, as did the first

- Submission of New Drug Application (NDA) for intravenous iclaprim in cSSSI initiated

- First patients enrolled in a Phase II trial with intravenous iclaprim in HAP/VAP/HCAP, an important potential second indication
- Progress of Phase I programme with oral iclaprim

- Promising results of 'first-in-man' studies with AR-709

- Novel antibiotic AR-2474 achieves preclinical proof of concept

- Raised CHF 51.9 million in a secondary offering in March 2007 - Late-stage antifungal therapy added to pipeline via acquisition of TLT Medical Ltd.
- Extensive presence at scientific conferences

- Cash and financial investments of CHF 68.1 million at 31 December 2007

Post-Year-End Events

- Oral iclaprim moves into Phase II efficacy trial in cSSSI

2008 Outlook - Completion of patient enrolment in Phase II trial with oral iclaprim in cSSSI

- Completion of patient enrolment in Phase II trial with intravenous iclaprim in

HAP/VAP/HCAP

- Completion of patient enrolment in Phase III trial with TLT in onychomycosis

- Regulatory review of NDA for intravenous iclaprim in cSSSI in USA

- Submission of application for marketing authorisation in EU

Dr Khalid Islam, President and CEO, commented: "We're tremendously proud of the progress we've achieved in the year under review. By early 2008, we have one product candidate in an NDA filing process, one product in a Phase III, and two additional Phase II development programs. We are expecting the filing of the NDA for intravenous iclaprim in cSSSI to be completed shortly. Mark
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
2. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
3. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
4. Arpida-Supported CME Symposium Available Online
5. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
6. Arpida Presents Preclinical Data on AR-2474 at ICAAC
7. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
8. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
9. Arpida Interim Results for six Months to 30 June 2007
10. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
11. WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Louisville, CO (PRWEB) March 26, 2015 ... agency has formed a strategic alliance with Designing Gig ... to their clients. , “Forging this alliance ... company. Now we can extend a comprehensive, end-to-end, ... design, development, strategy, and execution,” said Chuck Miller, president ...
(Date:3/26/2015)... CINCINNATI , March 26, 2015 ... SHPG ) and Cincinnati Children,s Hospital Medical Center ... rare diseases. The goal of the collaboration is to ... diseases with high unmet medical need combining Shire,s ... expertise. As a nationally ranked hospital, Cincinnati Children,s ...
(Date:3/26/2015)... PAREXEL International Corporation (Nasdaq: ... organization , announced today that the Company ... all of the business assets of privately-owned Quantum ... specialized pharmacovigilance services, based in Chandigarh, India.  ... monitoring, and prevention of adverse effects with ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 "In America," the ... the United States that is hosted by legendary film actor ... topic of botany in an upcoming segment. , Botany ... in reality it is actually quite a bit more complicated ... of different types of living organisms, from the smallest bacteria ...
Breaking Biology Technology:The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4
... 2011 Biocept, Inc., a privately-held laboratory testing ... of circulating tumor cells (CTCs) in cancer patients, ... the identification of different CTC phenotypes using its ... paper, appearing in the Journal of Oncology ...
... 2011 DATATRAK International, Inc. (OTCQX: DATA), a technology ... the clinical trials industry, today announces the expansion of ... Technical Community College (DTCC) to license its DATATRAK eClinical® ... eClinical software in its Clinical Trials Research program and ...
... 2011 The Laboratory Department for Probiotics Research ... (NAGATA Satoru, YAMASHIRO Yuichiro et al.) studied supplementation ... Shirota (LcS) in elderly individuals living at a ... acute norovirus gastroenteritis. Analysis of ...
Cached Biology Technology:Biocept Demonstrates Multiple Phenotypes of Circulating Tumor Cells (CTCs) in Cancer Patients 2Biocept Demonstrates Multiple Phenotypes of Circulating Tumor Cells (CTCs) in Cancer Patients 3DATATRAK Academy Expands to Include Durham Technical Community College 2DATATRAK Academy Expands to Include Durham Technical Community College 3Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 2Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 3
(Date:3/17/2015)... DIEGO , March 17, 2015 ... emotion analytics software, today announced general availability of ... web service for the analysis of facial expressions. ... experience advertising, media content, products and services. It ... attention, engagement and sentiment - as derived from ...
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
(Date:3/11/2015)... , March 11, 2015   The Sync ... platform to scientifically measure and harness music to ... real-time biometrics and objective measurements of physiology, enabling ... at scale in large populations. It is designed ... and clinicians perform rigorous studies and accelerate the ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... of Leicester in collaboration with Northamptonshire Police is ... John Bond, from Northamptonshire Police Scientific Support Unit ... of Leicester,s Forensic Research Centre developed- in collaboration ... fingerprints, even after the print itself has been ...
... June 22 The Federal Bureau of Investigation (FBI) ... a five-year, $47 million contract to continue managing the ... Service (CSS) program. The contract covers the conversion of ... electronic records for the FBI. , , ...
... Delays in cargo screening significantly extend the time of ... foolproof and rapid screening and detection systems. At the ... need for efficient access control systems in ports and ... , , New analysis from Frost & Sullivan ...
Cached Biology News:New advance in revolutionary 'bullet fingerprinting' technique 2Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan 3
Normal donkey serum collected from healthy normal donkeys....
This BioSolution package is excellent for doing fluorescence thermal melt experiments on nucleic acids, studies involving biomolecular interactions, protein folding experiments, and more!...
... Fc OxyBURST Green reagent (F-2902) was developed ... University to permit measurement of the kinetics ... subsequent oxidative burst directly in the phagovacuole.2 ... of bovine serum albumin (BSA) that has ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Biology Products: